Alexandria Venture Investments
Investor profile
Venture capital
Deals
2
distinct rounds
Companies
2
backed
Active span
2021–2025
5 yrs
Total round €
€200M
sum of rounds joined
Deals by year
distinct rounds / yearTop sectors
by dealsStages
by dealsCountries
by dealsCo-investment network
shared roundsHover a node for shared-deal counts; click a co-investor to open its profile.
Frequent co-investors
shared rounds- +ND Capital1
- 4see Ventures1
- Agilent Technologies1
- Apollo Health Ventures1
- Arrowmark Partners1
- Athos Capital1
- Bernina BioInvest1
- Bpifrance Large Venture1
- Casdin Capital1
- Columbia Threadneedle Investments1
- Danaher Life Sciences1
- Earlybird Venture Capital1
- Eli lilly and company1
- Farallon Capital1
- Fidelity Management and Research Company1
- Illumina Ventures1
- Kurma Partners1
- LifeLink Ventures1
- Longview Ventures1
- LSP1
- M Ventures1
- Moore Strategic Ventures1
- Schroders Capital1
- Sofinnova Partners1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| DNA Script | France | 1 | €142M |
| haya therapeutics | Switzerland | 1 | €57M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| DNA Script | Series C | €142M | 2021-10 |
| haya therapeutics | Series A | €57M | 2025-05 |